Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters

Biochemical and Biophysical Research Communications

Volumn 367, Issue 1, 2008, Pages 190-194

  Cho, Il Jin ^a   Ahn, Ji Yun ^a   Kim, Suna ^a   Choi, Myung Sook ^b   Ha, Tae Youl ^a  

^a Korea Food Research Institute   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

Cholesterol; Hamster; HMG Co A reductase; Resveratrol

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; FENOFIBRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LIPOPROTEIN A; RESVERATROL; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HAMSTER; HYPERLIPIDEMIA; LIPID DIET; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CRICETINAE; DIETARY FATS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HYDROXYMETHYLGLUTARYL COA REDUCTASES; LIPIDS; LIVER; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STILBENES; TIME FACTORS; TRIGLYCERIDES;

CRICETINAE; MESOCRICETUS AURATUS;

EID: 38049088068     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.12.140     Document Type: Article

References (25)

1. Miller J.P. Hyperlipidaemia and cardiovascular disease. Curr. Opin. Lipidol. 7 (1996) U18-U24
2. Packard C.J. Overview of fenofibrate. Eur. Heart J. 19 (1998) A62-A65
3. Sgro C., and Escousse A. Side effects of fibrates (except liver and muscle). Therapie 46 (1991) 351-354
4. Superko H.R. Drug therapy and the prevention of atherosclerosis in humans. Am. J. Cardiol. 64 (1989) 31G-38G
5. Kopp P. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the French paradox. Eur. J. Endocrinol. 138 (1998) 619-620
6. Sevov M., Elfineh L., Cavelier L.B., and Cavelier L.B. Resveratrol regulates the expression of LXR-α in human macrophages. Biochem. Biophys. Res. Commun. 348 (2006) 1047-1054
7. Auger C., Teissedre P.L., Gerain P., Lequeux N., Bornet A., Serisier S., Besancon P., Caporiccio B., Cristol J.P., and Rouanet J.M. Dietary wine phenolics catechin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation. J. Agric. Food Chem. 53 (2005) 2015-2021
8. Fremont L., Belguendouz L., and Delpal S. Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids. Life Sci. 64 (1999) 2511-2521
9. Wang Z., Huang Y., Zou J., Cao K., Xu Y., and Wu J.M. Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. Int. J. Mol. Med. 9 (2002) 77-79
10. Araim O., Ballantyne J., Waterhouse A.L., and Sumpio B.E. Inhibition of vascular smooth muscle cell proliferation with red wine and red wine polyphenols. J. Vasc. Surg. 35 (2002) 1226-1232
11. Tsai S.H., Lin-Shiau S.Y., and Lin J.K. Suppression of nitric oxide synthase and the down-regulation of the activation of NF(B in macrophages by resveratrol. Br. J. Pharmacol. 126 (1999) 673-680
12. Avellone G., Di Garbo V., Campisi D., De Simone R., Raneli G., Scaglione R., and Licata G. Effects of moderate Sicilian red wine consumption on inflammatory biomarkers of atherosclerosis. Eur. J. Clin. Nutr. 60 (2006) 41-47
13. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 (1957) 497-509
14. Hulcher M.W., and Oleson W.H. Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A. J. Lipid Res. 14 (1973) 625-631
15. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
16. Shapiro D.J., Nordstrom J.L., Mitschelen J.J., Rodwell V.W., and Schimke R.T. Micro assay for 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver and in L-cell fibroblasts. Biochim. Biophys. Acta 370 (1974) 369-377
17. Guo Q., Wang P.R., Milot D.P., Ippolito M.C., Hernandez M., Burton C.A., Wright S.D., and Chao Y. Regulation of lipid metabolism and gene expression by fenofibrate in hamsters. Biochim. Biophys. Acta 1533 (2001) 220-232
18. Wissler R.W. Theories and new horizons in the pathogenesis of atherosclerosis and the mechanisms of clinical effects. Arch. Pathol. Lab. Med. 116 (1992) 1281-1291
19. Miura D., Miura Y., and Yagasaki K. Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats. Life Sci. 73 (2003) 1393-1400
20. Wilson T., Knight T.J., Beitz D.C., Lewis D.S., and Engen R.L. Resveratrol promotes atherosclerosis in hypercholesterolemic rabbits. Life Sci. 59 (1996) PL15-PL21
21. Stein Y., Davach Y., Hollander G., and Stein O. Cholesteryl ester transfer protein activity in hamster plasma increased by fat and cholesterol rich diets. Biochem. Biophys. Acta 1042 (1990) 138-141
22. Sonia V.L., Reyna Luz V.Q., and Maria L.F. Sex and hormonal status influence plasma lipid responses to psyllium. Am. J. Clin. Nutr. 74 (2001) 435-441
23. Seifalian A.M., Piasecki C., Agarwal A., and Davidson B.R. The effect of graded steatosis on flow in the hepatic parenchymal microcirculation. Transplantation 68 (1999) 780-784
24. Istvan E.S. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Am. Heart J. 144 (2002) S27-S32
25. Endo A. The discovery and development of HMG-CoA reductase inhibitors. J. Lipid Res. 33 (1992) 1569-1582